Skip to main content
Joshua Zeidner, MD

January 14, 2020

Phase I study indicates drug could boost immune function in blood cancers

An early-stage clinical study investigating a method of boosting the body’s defenses against two blood cancers found the drug pomalidomide could be safely added to conventional treatments, and help improve immune function. University of North Carolina Lineberger Comprehensive Cancer Center researcher Joshua Zeidner, MD, assistant professor in the UNC School of Medicine Division of Hematology/Oncology, …

Headshot of Matthew Painschab

October 21, 2019

NIH awards grant to Painschab to improve multicentric Castleman disease treatment in Malawi

The National Institutes of Health Fogarty International Center has awarded Matthew Painschab, MD, a five-year International Research Scientist Development Award to lead research into improving treatment for multicentric Castleman disease in Malawi. Working through the University of North Carolina Project-Malawi, a collaboration between UNC-Chapel Hill and the Malawi Ministry of Health, Painschab will lead a …

Jen Jen Yeh

October 21, 2019

Researchers develop method for separating tissue types in tumor samples

A dense web of tissue can surround pancreatic cancer tumors, impeding treatment and sometimes acting as a barrier to the tumor’s spread. Jen Jen Yeh, MD, and colleagues have published a paper in Nature Communications that demonstrates their novel approach to distinguishing cancerous tissue from the surrounding connective tissue and stromal cells as well as from immune cells in the tumor’s environment in order to drive personalized treatment strategies.